AgraFlora Organics Completes Construction of Pharma-Grade R&D Laboratory at 51,500 Sq. Ft. GMP Winnipeg Edibles Facility
November 21 2019 - 3:05AM
AgraFlora Organics International Inc.
(“
AgraFlora” or the “
Company”)
(
CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF),
a growth oriented and diversified international cannabis company,
is pleased to announce the Company has completed construction of
its pharmaceutical-grade research and development laboratory (the
“R&D Laboratory”) at its 51,500 square foot GMP edibles
manufacturing facility in Winnipeg, Manitoba (the “Winnipeg Edibles
Facility”).
The Company’s 750 square foot, turnkey R&D Laboratory boasts
a comprehensive suite of made-to-order cannabinoid-testing and
product formulation equipment, including:
- Microbiological testing instruments;
- High Performance Liquid Chromatography (“HPLC”);
- Custom confectionery testing, manufacturing and
origination/formulation technologies;
- Deposit throughput in excess of 1,000 pieces of premium
chocolates or gummy edibles per hour;
- Proprietary triple shot depositor capable of producing infused
chocolate or liquid filled centre in shell pieces, as well as a
full vacuum pressure confectionery-cooking system.
The Company's Winnipeg Edibles Facility is also equipped with
the ability to formulate and mass-produce cannabinoid-infused
fruit/vegetable purees, which conform to the more rigorous Cannabis
2.0 regulations instilled by the Province of Quebec. This unique
product development capability will permit the capture of
defendable market share of the edibles, topicals and concentrates
industry in Canada's second most populous province. As announced on
November 8, 2019, AgaFlora intends to initially produce four pectin
and/or gelatine based CBD or THC infused gummy SKUs branded with
Mesoamerican attributes.
AgraFlora also announces that the Company is in the process of
finalizing product formulation, contract manufacturing and R&D
agreements with various Canadian Licensed Producers (“LPs”). The
Company forecasts that its R&D Laboratory will emerge as a hub
for innovation, as well as set the industry’s benchmark standard
for the industrial-scale production of value-added cannabis
products. AgraFlora’s R&D Laboratory will be fully operational
upon receipt of Health Canada issued research and development
license.
AgraFlora’s Winnipeg Edibles Facility is equipped with over
30,000 square feet of dedicated edibles production space. Once
activated, the Winnipeg Edibles Facility will be operated by a
roster of third generation chocolatiers/confectioners and boasts
state-of-the-art manufacturing equipment capable of producing an
assortment of both cannabinoid/terpene-infused products for
medicinal, functional and adult use.
The Winnipeg Edibles Facility is outfitted with fully automated
production flows; therefore, reducing associated labour costs and
optimizing product throughput, as follows:
- Cooking automation: The Winnipeg Edibles
Facility's confectionery line is powered by a custom, made-to-order
cooking and mixing system. Recipes are programmed into the
confectionery line's operating system and are queued for production
runs. Once the production run is initiated, pumping, and heating,
mixing, and the cooking of formulations is executed in continuous
automated process, requiring no human intervention.
- Depositing automation: A starchless
confectionery mogul corrals the cooked cannabis infused
confectionery and deposits the product into silicon moulds, with
resulting deposit accuracy of greater than 99.5 per cent. Flavours,
colours and cannabis oil can be substituted during production runs,
with no downtime required for changeovers. The confectionery is
then automatically cooled, demoulded, sour sanded or oiled and then
individually wrapped. From the moment ingredients arrive at the
plant to the time products emerge as finished cannabis-infused
edibles, no manual processes or human intervention are
required.
- Packaging automation: The Winnipeg Edibles
Facility is equipped with industrial high-speed packaging
infrastructure that can wrap, bag and bottle cannabis edibles at
speeds exceeding 15,000 packages per hour. Excise stamps are
robotically applied to the packages and they are packed into
finished cases leveraging automated pick and place systems.
Brandon Boddy, Chairman and Chief Executive Officer of AgraFlora
stated: “The completion of our pharma-grade R&D Laboratory
positions us to secure consistent cash flows as a result of product
formulation and contract manufacturing agreements with our peers.
We had the corporate foresight to invest in state-of-the-art plant,
property and equipment prior to the arrival of cannabis 2.0, of
which inherent value continues to be evidenced by growing market
demand. Armed with this state-of-the-art facility, we expect to
become the unequivocal leader within the highly lucrative
cannabinoid-infused edibles and functional food marketplaces.”
About AgraFlora Organics International Inc.
AgraFlora Organics International Inc. is a growth oriented and
diversified company focused on the international cannabis industry.
It owns an indoor cultivation operation in London, ON and is a
joint venture partner in Propagation Services Canada Inc. and its
large-scale 2,200,000 sq. ft. greenhouse complex in Delta, BC. The
Company is also retrofitting a 51,500-square-foot good
manufacturing practice (“GMP”) edibles manufacturing facility in
Winnipeg, Manitoba. AgraFlora has a successful record of creating
shareholder value and is actively pursuing other opportunities
within the cannabis industry. For more information please visit:
www.agraflora.com.
ON BEHALF OF THE BOARD OF DIRECTORS
Brandon Boddy Chairman & CEOT: (604) 398-3147
For additional information:
AgraFlora Organics International Inc. Tim
McNultyE: ir@agraflora.com T: (800) 783-6056 |
For French
inquiries: Remy Scalabrini, Maricom Inc.E: rs@maricom.ca T:
(888) 585-MARI |
The CSE and Information Service Provider have
not reviewed and does not accept responsibility for the accuracy or
adequacy of this release.
Forward-looking Information Cautionary
Statement
Except for statements of historic fact, this
news release contains certain "forward-looking information" within
the meaning of applicable securities law. Forward-looking
information is frequently characterized by words such as "plan",
"expect", "project", "intend", "believe", "anticipate", "estimate"
and other similar words, or statements that certain events or
conditions "may" or "will" occur. Forward-looking statements are
based on the opinions and estimates at the date the statements are
made, and are subject to a variety of risks and uncertainties and
other factors that could cause actual events or results to differ
materially from those anticipated in the forward-looking statements
including, but not limited to delays or uncertainties with
regulatory approvals, including that of the CSE. There are
uncertainties inherent in forward-looking information, including
factors beyond the Company’s control. There are no assurances that
the business plans for AgraFlora Organics described in this news
release will come into effect on the terms or time frame described
herein. The Company undertakes no obligation to update
forward-looking information if circumstances or management's
estimates or opinions should change except as required by law. The
reader is cautioned not to place undue reliance on forward-looking
statements. Additional information identifying risks and
uncertainties that could affect financial results is contained in
the Company’s filings with Canadian securities regulators, which
are available at www.sedar.com.
Agra Ventures (CSE:AGRA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Agra Ventures (CSE:AGRA)
Historical Stock Chart
From Jul 2023 to Jul 2024